• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC. NOVASURE SURESOUND; DEVICE, THERMAL ABLATION, ENDOMETRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC. NOVASURE SURESOUND; DEVICE, THERMAL ABLATION, ENDOMETRIAL Back to Search Results
Model Number 2007
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Uterine Perforation (2121)
Date of Event 02/24/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A device history record (dhr) review was conducted for the reported lot/serial number.The device was released meeting all qa specifications.We are currently unable to establish a relationship between the device and the issue reported.The device involved in this event was not returned for evaluation purposes therefore visual and functional analysis of the product could not be performed.We are unable to confirm a relationship between the device and the issue reported and a definitive root cause for the reported event could not be determined.The information obtained during complaint investigation will be included in our global complaint trending and product surveillance will continue to monitor complaints of this type for adverse trends.If the product is received or additional information is obtained, the investigation will be reopened accordingly per standard operating procedure.3 devices were used in this procedure all reported under: 1222780-2022-00084 and 1222780-2022-00086.
 
Event or Problem Description
It was reported that on (b)(6) 2022 , during a novasure procedure, an uterine perforation was observed.No other information is available.
 
Additional Manufacturer Narrative
Device received and examined.Visual inspection was performed and there were no sharp edges that could cause a perforation.The functional test was performed and the cavity initial assessment failed.The complaint could not be confirmed.A device history record (dhr) review was conducted for the reported lot/serial number.The device was released meeting all qa specifications.We are currently unable to establish a relationship between the device and the issue reported.H6: investigation findings: proposed code: functional testing failure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NOVASURE SURESOUND
Common Device Name
DEVICE, THERMAL ABLATION, ENDOMETRIAL
Manufacturer (Section D)
HOLOGIC, INC.
250 campus drive
marlborough, MA 01752
Manufacturer (Section G)
HOLOGIC, INC.
250 campus drive
marlborough, MA 01752
Manufacturer Contact
daniel guevara
562 parkway
coyol free zone building b24
san jose, alajuela 20102- CRI
CS   20102 CRI
MDR Report Key13774876
Report Number1222780-2022-00085
Device Sequence Number11768094
Product Code MNB
UDI-Device Identifier15420045501140
UDI-Public(01)15420045501140(10)21H31R(17)230324
Combination Product (Y/N)N
Initial Reporter StateSC
Initial Reporter CountryUS
PMA/510(K) Number
P010013
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 04/13/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/24/2023
Device Model Number2007
Device Catalogue NumberNS2007US
Device Lot Number21H31R
Was Device Available for Evaluation? Device Returned to Manufacturer
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/24/2022
Supplement Date Received by Manufacturer02/24/2022
Initial Report FDA Received Date03/15/2022
Supplement Report FDA Received Date04/13/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/31/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
NOVASURE GEN 3 (2).
Outcome Attributed to Adverse Event Other;
Patient SexFemale
-
-